Please enable JavaScript.
Coggle requires JavaScript to display documents.
Nerve stimulation (Market drivers (Population aging, Opioid epidemic,…
Nerve stimulation
Market drivers
Population aging
Opioid epidemic
Spread of non communicable/chronic diseases
Personalisation of medicine
Market analysis
Size
Geography
US
Top market
Mid growth
Europe
2nd market
Mid growth
Asia
High growth
Rest of the world
Limited market
Growth
7-13%
Applications
Diseases
Other Applications
Obsessive Compulsive Disorder (OCD)
Treatment-Resistant Depression (TRD)
Gastroparesis
Dystonia
Essential Tremor
Refractory Epilepsy
Urinary Fecal Incontinence
Parkinson's Disease
Chronic Pain
Largest market and number of patients
Technology
External
Transcutaneous Electrical Nerve Stimulation
Chronic pain
Commercially available
Transcranial Magnetic Stimulation
Internal
Peripheral Nerve Stimulation (PNS)
Chronic pain
Vagus Nerve Stimulation (VNS)
Epilepsy
Sacral Nerve Stimulation (SNS)
Urinary Fecal Incontinence
Deep Brain Stimulation (DBS)
Tremor
Parkinson's disease
Spinal Cord Stimulation (SCS)
Chronic pain
Competitors
PNS
SPS Therapeutics
3 products
FDA approved
Clinical trials successful
Bioness
FDA approved
Risks